John Canan's Net Worth
$5.49 Million
Who is John Canan?
John Canan has an estimated net worth of $5.49 Million. This is based on reported shares across multiple companies, which include Merck & Co. Inc., MERCK & CO INC, REV Group, Inc., and Acasti Pharma Inc..
SEC CIK
John Canan's CIK is 0001374366
Past Insider Trading and Trends
2009 was John Canan's most active year for acquiring shares with 23 total transactions. John Canan's most active month to acquire stocks was the month of October. 2009 was John Canan's most active year for disposing of shares, totalling 18 transactions. John Canan's most active month to dispose stocks was the month of October. 2014 saw John Canan paying a total of $646,052.34 for 12,913 shares, this is the most they've acquired in one year. In 2012 John Canan cashed out on 51,576 shares for a total of $2,223,370.57, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Merck & Co. Inc. (MRK) Snapshot price: $117.36
Sr.V-P Finc-Global Controller
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +27.23% | 2.91K |
$56.18 | $163,652.34 | 13.61K |
Feb 24
| |||
Form 4
|
—
|
0
|
$51.97 | -$74,602.00 | 10.7K |
Feb 11
| |||
Form 4
| +36.31% | 2.81K |
$44.98 | -$75,071.62 | 10.55K |
May 6 - May 7
| |||
Form 4
| +52.53% | 2.66K |
$42.52 | $112,975.64 | 7.71K |
Feb 25
| |||
Form 4
| -85.78% | -30.50K |
$44.29 | -$1,350,787.05 | 5.06K |
Aug 1
| |||
Form 4
| +20.96% | 6.16K |
$43.27 | -$152,310.40 | 35.56K |
Jul 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
| +14.45% | 3.67K |
$38.27 | -$80,367.00 | 29.11K |
Apr 24
| |||
Form 4
| +20.42% | 4.27K |
$38.38 | $163,805.84 | 25.17K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
| +18.65% | 3.15K |
$32.19 | -$57,942.00 | 20.04K |
Feb 28
| |||
Form 4
| +28.65% | 3.76K |
$32.34 | $121,630.74 | 16.89K |
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 4
| +23.47% | 2.39K |
$37.27 | -$50,836.28 | 12.55K |
Mar 2
| |||
Form 4
| +35.95% | 2.69K |
$37.72 | $101,391.36 | 10.17K |
Jan 8
| |||
Form 4
|
∞
| 9.88K |
—
|
—
|
0
|
Nov 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MERCK & CO INC No price found
Senior V-P, Controller
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -9.88K |
—
|
—
|
0
|
Nov 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 24
| |||
Form 4/A
| +19.12% | 1.15K |
$23.05 | $26,392.25 | 7.13K |
Mar 4
| |||
Form 4
| +15.70% | 940 |
$23.05 | $21,667.00 | 6.93K |
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 29
| |||
Form 4
| +28.07% | 1.27K |
$45.44 | $57,845.12 | 5.81K |
Feb 28
| |||
Form 4
| +26.96% | 963 |
$46.07 | -$32,433.28 | 4.54K |
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
|
∞
| 2.41K |
$44.79 | -$71,171.31 | 2.41K |
Jan 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
REV Group, Inc. (REVG) Snapshot price: $24.94
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +13.47% | 7.08K |
—
|
—
| 59.67K |
Dec 8
| |||
Form 4
| +17.84% | 7.96K |
—
|
—
| 52.59K |
Dec 8
| |||
Form 4
| +15.37% | 5.95K |
—
|
—
| 44.63K |
Dec 9
| |||
Form 4
| +37.66% | 10.58K |
—
|
—
| 38.69K |
Dec 11
| |||
Form 4
| +11.25% | 2.84K |
—
|
—
| 28.1K |
Feb 6
| |||
Form 4
| +44.55% | 7.8K |
—
|
—
| 25.3K |
Dec 18
| |||
Form 4
| +173.34% | 11.1K |
—
|
—
| 17.5K |
Jan 9
| |||
Form 4
| +380.95% | 5.04K |
$16.04 | $80,845.16 | 6.36K |
Jun 25
| |||
Form 4
|
∞
| 1.36K |
—
|
—
| 1.36K |
Jan 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Acasti Pharma Inc. (ACST) Snapshot price: $2.51
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||